TY - JOUR
T1 - A study of aminolevulinic acid-induced protoporphyrin IX fluorescence kinetics in the canine oral cavity
AU - Vaidyanathan, Vijay V.
AU - Rastegar, Sohi
AU - Fossum, Theresa W.
AU - Flores, Patricia
AU - Van Der Breggen, Egbertus W.
AU - Egger, Norman G.
AU - Jacques, Steven L.
AU - Motamedi, Massoud
PY - 2000
Y1 - 2000
N2 - Background and Objective: 5-Aminolevulinic acid-induced protoporphyrin IX is a promising photosensitizer that could enhance the spectroscopic contrast between normal and diseased oral tissues. Knowledge of the pharmacokinetics and effects on tissue type are important for diagnostic and therapeutic procedures. Study Design/Materials and Methods: Dogs randomly were administered five doses of 5-aminolevulinic acid: 5, 25, 50, 75, and 100 mg/kg. The fluorescence was recorded from buccal mucosa, gums, tongue, and facial skin using a fiberoptic probe connected to an optical multichannel analyzer. Blood samples were collected for hematologic and serum biochemical analysis. Pharmacokinetic parameters of interest were estimated using a compartmental model. Results: Protoporphyrin fluorescence at all sites reached a peak in 2-6 hours, and returned to baseline in 24-31 hours, depending on the dose. Plasma protoporphyrin peaked earlier than oral tissues. Conclusion: The rate of synthesis of protoporphyrin, and its conversion to heme products are dose dependent. Different tissues have different pharmacokinetic response. (C) 2000 Wiley-Liss, Inc.
AB - Background and Objective: 5-Aminolevulinic acid-induced protoporphyrin IX is a promising photosensitizer that could enhance the spectroscopic contrast between normal and diseased oral tissues. Knowledge of the pharmacokinetics and effects on tissue type are important for diagnostic and therapeutic procedures. Study Design/Materials and Methods: Dogs randomly were administered five doses of 5-aminolevulinic acid: 5, 25, 50, 75, and 100 mg/kg. The fluorescence was recorded from buccal mucosa, gums, tongue, and facial skin using a fiberoptic probe connected to an optical multichannel analyzer. Blood samples were collected for hematologic and serum biochemical analysis. Pharmacokinetic parameters of interest were estimated using a compartmental model. Results: Protoporphyrin fluorescence at all sites reached a peak in 2-6 hours, and returned to baseline in 24-31 hours, depending on the dose. Plasma protoporphyrin peaked earlier than oral tissues. Conclusion: The rate of synthesis of protoporphyrin, and its conversion to heme products are dose dependent. Different tissues have different pharmacokinetic response. (C) 2000 Wiley-Liss, Inc.
KW - Dosage
KW - In vivo
KW - Oral tissue
KW - Pharmacokinetics
UR - http://www.scopus.com/inward/record.url?scp=0034024911&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034024911&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1096-9101(2000)26:4<405::AID-LSM9>3.0.CO;2-E
DO - 10.1002/(SICI)1096-9101(2000)26:4<405::AID-LSM9>3.0.CO;2-E
M3 - Article
C2 - 10805946
AN - SCOPUS:0034024911
SN - 0196-8092
VL - 26
SP - 405
EP - 414
JO - Lasers in Surgery and Medicine
JF - Lasers in Surgery and Medicine
IS - 4
ER -